This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not a feature of Type II schizophrenia? a. Delusions and hallucinations ... (Read 147 times)

c0205847

  • Hero Member
  • *****
  • Posts: 531
Which of the following is not a feature of Type II schizophrenia?
 
  a. Delusions and hallucinations
  b. Intellectual impairment
  c. Cell loss in the temporal lobes
  d. Poor response to dopamine antagonist drugs

Question 2

TMS:
 
  a. Has been used to treat depression
  b. Is a noninvasive technique
  c. Uses a magnetic coil to induce electrical activity in brain tissue
  d. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chocorrol77

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

A

Answer to Question 2

D




c0205847

  • Member
  • Posts: 531
Reply 2 on: Jun 22, 2018
Excellent


ashely1112

  • Member
  • Posts: 347
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

Medication errors are three times higher among children and infants than with adults.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library